Balance Sheet (Annual)

ORGS / Orgenesis, Inc. Balance Sheet shows account balances for the company at points in time. Balance Sheet data includes Assets, Current Assets, Fixed Assets, Property, Plant and Equipment (PPE), Inventory, Intangibles, Liabilities, Current Liabilities, Debt, Capital Lease Obligations, Common Stock, Retained Earnings, Treasury Stock, and Shareholders Equity.

All numbers are times 1,000 except per share units.

2011 2012 2013 2014 2015 2016 2017
Assets
  Assets Current
    Cash Equivalents At Carrying Value 1 0 51 1,314 4,168 891 3,519
    Restricted Cash And Cash Equivalents - - - - 5 5 -
    Accounts Receivable Net Current - - - - 1,173 1,229 1,336
    Prepaid Expense Current 1 28 37 105 1,118 779 841
    Receivables Net Current - - - - - - 691
    Derivative Assets Current - - - - - - -
    Grants Receivable Current - - - 811 - - -
    Inventory Net - - - - 301 400 725
    Assets Current 2 39 98 2,230 8,206 4,205 7,295
Assets Noncurrent
  Derivative Assets Noncurrent - - - - - - 339
  Investments - - - - - - 1,321
  Property Plant And Equipment Net - 8 13 13 4,296 4,573 5,104
  Intangible Assets Net Excluding Goodwill - - - - 16,653 15,050 15,051
  Goodwill - - - - 9,535 9,584 10,684
  Other Assets Noncurrent - - - - 53 70 78
  Assets Noncurrent - - - - 30,542 29,282 32,577
Assets 2 48 114 2,249 38,748 33,487 39,872
Liabilities And Stockholders Equity
  Liabilities Current
    Accounts Payable Current 45 136 139 1,084 3,475 4,554 3,914
    Accrued Liabilities Current - 73 386 375 816 1,205 1,435
    Employee Related Liabilities Current - 76 155 626 1,348 1,680 2,961
    Due To Related Parties Current 36 42 42 42 42 42 116
    Advance Payment On Account Of Grant - - - 85 307 243 1,719
    Notes Payable Current - - - - 2,829 1,111 378
    Other Liabilities Current - - - - - - -
    Deferred Revenue Current - - - - 1,216 1,273 3,611
    Convertible Debt Current - - - - - 2,541 2,780
    Convertible Bonds - - - - 1,888 1,818 0
    Derivative Liabilities Current - - - - 1,533 76 -
    Investments In Associate Net - - - - - 12 0
    Liabilities Current - 327 986 4,663 16,476 14,576 16,914
  Liabilities Noncurrent
    Long Term Loans Payable - - - - - - 2,118
    Convertible Debt Noncurrent - - - - - 1,059 2,415
    Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent - - 4 5 5 5 6
    Deferred Income Taxes And Other Liabilities Noncurrent - - - - 3,327 1,862 690
    Other Liabilities Noncurrent - - - - - - -
    Liabilities Noncurrent - - 1,162 565 7,254 8,333 5,229
  Liabilities 85 329 2,149 5,228 23,730 22,909 22,143
Commitments And Contingencies - - - - 0 0 -
Redeemable Non Controlling Interest - - - - - - 3,606
Stockholders Equity
  Common Stock Value 8 5 5 6 6 12 1
  Additional Paid In Capital 47 4,850 8,635 13,153 14,229 41,605 55,334
  Common Stock Share Subscribed But Unissued Subscriptions Receivable - - - -60 -1,251 0 -1,483
  Accumulated Other Comprehensive Income Loss Net Of Tax - - - -18 -1,286 -1,205 1,425
  Retained Earnings Accumulated Deficit - - - -16,179 -20,640 -29,834 -44,120
  Stockholders Equity -83 -281 -2,034 -2,979 -6,440 10,578 14,123
  Liabilities And Stockholders Equity 2 48 114 2,249 38,748 33,487 39,872

Peers - Pharmaceutical Preparations (2834)

Related News Stories

Orgenesis, Inc. - Overlooked Stock In The Gene Therapy Contract Development With R&D Pipeline

2018-06-03 seekingalpha
Overlooked specialty contract development and manufacturing stock in the exciting field of advanced cell therapy with a potential for an exponential upside. (184-3)

CUSIP: 68619K105